New statement: Patients with PIDs should have access to safe, efficacious and high-quality immunoglobulin therapies
Key publications, News /by IPOPIContact us
Belgium
Avenue Louise/Louizalaan 65, Bte 11
BE-1050 Brussels, Belgium
IPOPI aisbl is an international non-profit association registered in Belgium
Numéro d’entreprise
BE 0761.784.055
Email: info@ipopi.org
Tel: +32 2 790 73 66 (Belgium)